21-37188523-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001330683.2(TTC3):c.4952G>A(p.Ser1651Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000479 in 1,613,800 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330683.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC3 | NM_001330683.2 | c.4952G>A | p.Ser1651Asn | missense_variant | 39/46 | ENST00000418766.6 | NP_001317612.1 | |
TTC3-AS1 | NR_046651.1 | n.240C>T | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC3 | ENST00000418766.6 | c.4952G>A | p.Ser1651Asn | missense_variant | 39/46 | 5 | NM_001330683.2 | ENSP00000403943 | P2 | |
TTC3-AS1 | ENST00000424733.1 | n.240C>T | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251318Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135824
GnomAD4 exome AF: 0.000507 AC: 741AN: 1461684Hom.: 2 Cov.: 30 AF XY: 0.000512 AC XY: 372AN XY: 727142
GnomAD4 genome AF: 0.000210 AC: 32AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | The c.4952G>A (p.S1651N) alteration is located in exon 39 (coding exon 38) of the TTC3 gene. This alteration results from a G to A substitution at nucleotide position 4952, causing the serine (S) at amino acid position 1651 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at